Camphane chlorobenzamideКамфановый хлорбензамид
An experimental chlorobenzamide designed as a structural analogue of Chlodantane. It has a camphane cage in place of Chlodantane’s adamantane cage.
What the studies found
Animal research · 2023
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
Study of multiple preparations
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
Study notes · methods, sources and limitations
Participants or model Mouse pharmacology experiments
Important limitations
- Abstract-level animal findings do not establish human performance benefits or improved clinical safety. An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose. The Russian and English versions are one publication, not independent replication.
Pharmaceutical Chemistry Journal. 57(4):523–534 · Publication record
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
Study of multiple preparations
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
Study notes · methods, sources and limitations
Participants or model Chemical synthesis and characterization; background pharmacology citations
Important limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy. ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Russian Journal of General Chemistry. 89(3):399–404 · Publication record
Laboratory analysis · 2019
Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction
Study of multiple preparations
Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
Study notes · methods, sources and limitations
Participants or model Preclinical research; no human efficacy established
Important limitations
- Chemistry and preclinical observations do not establish human efficacy or safety.
Zhurnal Organicheskoi Khimii. 55(11):1781–1788 · Publication record
About Camphane chlorobenzamide
Names in this research collection
N-[(1R,2RS)-camphan-2-yl]-4-chlorobenzamide
Research background
An experimental camphane-based structural analogue of Chlodantane. The cage framework differs from adamantane; this is a chemical candidate, not an established treatment.
- Compound class
- Experimental adamantane / analogue
- Research collection
- Actoprotection & occupational pharmacology · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
Human efficacy results unavailable
Study methods
Source-specific animal, chemistry, patent or dissertation evidence
Independent replication
Independent replication not established; translations are not separate experiments
Source access
Access and review depth appear with each linked record
Safety evidence
Human safety and interactions not established; animal activity is not a safe-use recommendation
Open a topic for the evidence assessment.
Findings by study
Animal research · 2023
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
Study notes and original source
Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
A. A. Vernigora, R. V. Brunilin, O. V. Vostrikova, et al. · Pharmaceutical Chemistry Journal. 57(4):523–534
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
- Population / setting
- Mouse pharmacology experiments
- Source reviewed
- Institute abstract and selected author-uploaded full-text passages checked, including the 7/14-day schedule and baseline-imbalance discussion; complete tables not independently appraised.
Study limitations
- Abstract-level animal findings do not establish human performance benefits or improved clinical safety.
- An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose.
- The Russian and English versions are one publication, not independent replication.
Reviewed 2026-10-03.
Laboratory analysis · 2019
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
Study notes and original source
Synthesis of New Camphane-Type Amides: Potential Synthetic Adaptogenes
I. A. Novakov, R. V. Brunilin, G. M. Butov, A. A. Vernigora, M. B. Navrotskii, A. S. Yablokov, S. N. Voloboev · Russian Journal of General Chemistry. 89(3):399–404
The study reports synthesis and characterization of camphane analogues and links their design to Chlodantane and related adamantanes. ADK-957 appears as a chlorophenoxyacetamide background lead; cited cold-protection activity is not a new clinical result in this chemistry paper.
- Population / setting
- Chemical synthesis and characterization; background pharmacology citations
- Source reviewed
- Author-uploaded paper’s accessible chemistry/background passages checked; earlier pharmacology not independently recovered.
Study limitations
- Chemical characterization and a potential-adaptogen label do not demonstrate pharmacological efficacy.
- ADK-957’s original cold-exposure experiment and detailed safety data remain acquisition targets.
Reviewed 2026-10-03.
Laboratory analysis · 2019
Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction
Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
Study notes and original source
Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction
· Zhurnal Organicheskoi Khimii. 55(11):1781–1788
Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
- Population / setting
- Preclinical research; no human efficacy established
- Source reviewed
- Source identity and selected abstract or text passages checked; complete methods not appraised.
Study limitations
- Chemistry and preclinical observations do not establish human efficacy or safety.
Reviewed 2026-10-03.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗